FDA

News

AZ's COPD triple therapy approved in the US

AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the US following a re

News

Mallinckrodt’s liver disease drug terlipressin edges FDA adv...

An FDA advisory committee has narrowly voted in favour of approval of Mallinckrodt’s terlipressin for hepatorenal syndrome type 1 (HRS-1), after the agency questioned the findi

News

FDA experts okay GSK's multiple myeloma drug despite safety ...

GlaxoSmithKline’s potential first-in-class multiple myeloma drug belantamab mafodotin has taken a step closer to US approval after unanimous backing from a panel of expert advisers convened

News

FDA reviewer warns of eye trouble with GSK’s myeloma ADC

GlaxoSmithKline heads for an FDA advisory committee meeting this week for belantamab mafodotin – its much-touted treatment for multiple myeloma – with a question about safety h

News

FDA grants fast review of AZ's Brilinta to prevent recurring...

The FDA has granted a fast review of AstraZeneca’s cardiovascular diseases drug Brilinta (ticagrelor) in the new indication that aims to reduce the chances of patients having recurring stro

News

FDA backs second rare disease drug from Ultragenyx in the sp...

The FDA has approved a second rare disease drug from California-based Ultragenyx in the space of a fortnight, for treatment of long-chain fatty acid oxidation disorders.

AZ's COPD triple therapy approved in the US

Mallinckrodt’s liver disease drug terlipressin edges FDA adv...

FDA experts okay GSK's multiple myeloma drug despite safety ...

FDA reviewer warns of eye trouble with GSK’s myeloma ADC

FDA grants fast review of AZ's Brilinta to prevent recurring...

FDA backs second rare disease drug from Ultragenyx in the sp...

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks